Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gritstone Bio Inc (NQ: GRTS )

0.0322 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Gritstone Bio Inc

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Gritstone Bio (GRTS) Stock Is Down 64% Today
Gritstone bio shares are trading lower by 65% during Thursday's session. The company announced it voluntarily filed for Chapter 11 restructuring. 
Via Benzinga
Key Takeaways From Gritstone Bio Analyst Ratings
Via Benzinga
Where Gritstone Bio Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Dow Falls Over 100 Points; US Inflation Rate Slows To 2.4% In September
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure
From Gritstone bio, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Penny Stock Gritstone Bio Hires Advisor To Evaluate Options, Analyst Downgrades Stock As Data 'Insufficient To Excite Many Investors'
Gritstone Bio's Phase 2 data for GRANITE in MSS-CRC shows promising results, including a 38% risk reduction for patients with low ctDNA. Gritstone plans to review the data with the FDA for potential... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer
From Gritstone bio
Via GlobeNewswire
GRTS Stock Earnings: Gritstone Bio Beats EPS, Misses Revenue for Q2 2024
GRTS stock results show that Gritstone Bio beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
From Gritstone bio
Via GlobeNewswire
GRITSTONE ALERT: Bragar Eagel & Squire, P.C. is Investigating Gritstone bio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
GRTS Investors Have Opportunity to Join Gritstone bio, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
GRTS Deadline: Rosen Law Firm Urges Gritstone bio, Inc. (NASDAQ: GRTS) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
GRTS Investors Have Opportunity to Join Gritstone bio, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Scotts, Gritstone, Fat Brands, and Charge and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.